FDA chief requests probe into own agency’s dealings with pharma firm before controversial approval for Alzheimer’s drug

Follow RT on Acting FDA head Janet Woodcock has called for an independent probe into potentially inappropriate contacts between FDA staff and a pharma firm, after the agency drew controversy for approving the company’s dementia drug. In a letter published on Friday, the acting Food and Drug Administration commissioner asked…

read more